These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 24034049)
1. A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report. Ranghino A; Tognarelli G; Basso E; Messina M; Manzione AM; Daidola G; Segoloni GP Transplant Proc; 2013 Sep; 45(7):2785-7. PubMed ID: 24034049 [TBL] [Abstract][Full Text] [Related]
2. Successful long-term outcome after renal transplantation in a patient with atypical haemolytic uremic syndrome with combined membrane cofactor protein CD46 and complement factor I mutations. Pabst WL; Neuhaus TJ; Nef S; Bresin E; Zingg-Schenk A; Spartà G Pediatr Nephrol; 2013 Jul; 28(7):1141-4. PubMed ID: 23519521 [TBL] [Abstract][Full Text] [Related]
3. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. Chan MR; Thomas CP; Torrealba JR; Djamali A; Fernandez LA; Nishimura CJ; Smith RJ; Samaniego MD Am J Kidney Dis; 2009 Feb; 53(2):321-6. PubMed ID: 18805611 [TBL] [Abstract][Full Text] [Related]
4. Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP. Cruzado JM; de Córdoba SR; Melilli E; Bestard O; Rama I; Sánchez-Corral P; López-Trascasa M; Navarro I; Torras J; Gomà M; Grinyó JM Am J Transplant; 2009 Jun; 9(6):1477-83. PubMed ID: 19459807 [TBL] [Abstract][Full Text] [Related]
5. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452 [TBL] [Abstract][Full Text] [Related]
6. Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation. Noris M; Remuzzi G Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):704-12. PubMed ID: 24076560 [TBL] [Abstract][Full Text] [Related]
7. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series. Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363 [TBL] [Abstract][Full Text] [Related]
8. Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation. Sinibaldi S; Guzzo I; Piras R; Bresin E; Emma F; Dello Strologo L Pediatr Transplant; 2013 Dec; 17(8):E177-81. PubMed ID: 24118826 [TBL] [Abstract][Full Text] [Related]
9. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Nilsson SC; Karpman D; Vaziri-Sani F; Kristoffersson AC; Salomon R; Provot F; Fremeaux-Bacchi V; Trouw LA; Blom AM Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897 [TBL] [Abstract][Full Text] [Related]
10. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations. Alberti M; Valoti E; Piras R; Bresin E; Galbusera M; Tripodo C; Thaiss F; Remuzzi G; Noris M Am J Transplant; 2013 Aug; 13(8):2201-6. PubMed ID: 23731345 [TBL] [Abstract][Full Text] [Related]
11. Atypical hemolytic uremic syndrome: update on the complement system and what is new. Hirt-Minkowski P; Dickenmann M; Schifferli JA Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363 [TBL] [Abstract][Full Text] [Related]
12. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Hirt-Minkowski P; Schaub S; Mayr M; Schifferli JA; Dickenmann M; Frémeaux-Bacchi V; Steiger J Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317 [TBL] [Abstract][Full Text] [Related]